ArticleFood science & nutrition2025
Spatial Domain-Based Approach to Analyze the Mechanism of Sparganii Rhizoma-Curcumae Rhizoma Pair in the Treatment of Colorectal Cancer.
Article in Food science & nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Spatial Domain-Based Approach to Analyze the Mechanism of Sparganii Rhizoma-Curcumae Rhizoma Pair in the Treatment of Colorectal Cancer.Food science & nutrition · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Colorectal cancer (CRC) is a global health challenge shaped by a complex tumor microenvironment (TME), where myeloid-driven inflammatory and immunosuppressive processes play central roles. Understanding the spatial and dynamic interactions within the TME is essential for uncovering novel regulatory mechanisms. We integrated spatial transcriptomics, single-cell RNA-sequencing, and network pharmacology to develop a comprehensive analytical framework for deconstructing cellular and molecular interactions across spatial domains within the TME. Using this approach, we investigated the potential mechanisms by which the Sparganii Rhizoma-Curcumae Rhizoma (SCP) Chinese medicine (TCM) herbal pair may influence primary CRC and liver metastases. Our analysis suggests that in primary CRC, SCP may affect neutrophil-enriched domains through modulation of CEACAM-related signaling, while in liver metastases, it may influence macrophage-dominated domains associated with APP signaling. These findings highlight possible domain-specific molecular interactions and suggest that SCP may regulate intra- and inter-domain signaling patterns relevant to TME remodeling. This study establishes a novel integrative methodology to investigate spatial domain-specific mechanisms within the TME. Our findings reveal the multi-dimensional effects of SCP, providing a precision-targeted, TME-centric therapeutic strategy for CRC. The framework aligns with TCM principles and offers new avenues for personalized cancer therapies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.